Novak Djokovic and his wife own 80% of a Danish biotech firm looking to create a treatment for COVID-19 that bypasses vaccination.
The tennis star is the controlling shareholder of QuantBioRes, a company working to develop a treatment with a “deactivation mechanism” for COVID-19, according to the company’s website.
<mediadc-video-embed data-state="{"cms.site.owner":{"_ref":"00000161-3486-d333-a9e9-76c6fbf30000","_type":"00000161-3461-dd66-ab67-fd6b93390000"},"cms.content.publishDate":1642634220604,"cms.content.publishUser":{"_ref":"0000017d-8cce-d87c-af7f-ddce9ca80000","_type":"00000161-3461-dd66-ab67-fd6b933a0007"},"cms.content.updateDate":1642634220604,"cms.content.updateUser":{"_ref":"0000017d-8cce-d87c-af7f-ddce9ca80000","_type":"00000161-3461-dd66-ab67-fd6b933a0007"},"rawHtml":"
var _bp = _bp||[]; _bp.push({ "div": "Brid_42603536", "obj": {"id":"27789","width":"16","height":"9","video":"942543"} }); ","_id":"0000017e-74a1-de39-a1ff-75f30b710000","_type":"2f5a8339-a89a-3738-9cd2-3ddf0c8da574"}”>Video Embed
Ivan Loncarevic, QuantBioRes’s chief executive, confirmed Djokovic’s investment to Reuters. He said he had not spoken to the tennis star since November and that Djokovic is “not anti-vax,” according to a report.
The biotech company includes 11 researchers who are working in Denmark, Australia, and Slovenia to develop the treatment that Loncarevic stressed is not a vaccine. Clinical trials are reportedly set to launch this summer.
CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER
Djokovic missed out on defending his Australian Open title this week after his COVID-19 vaccination exemption was denied by the country. He risks not being able to compete in future tournaments due to current COVID-19 restrictions.
